Generation Trader, sponsored by E*Trade, follows and highlights the most compelling business stories that are moving the market. This episode features Netflix ahead of its latest earnings report, with E*Trade's Senior Equity Option Strategist Mary Ryan. Shares of Netflix are already up nearly 18 percent this year, and on Monday shares are trading at all-time highs. Netflix stock has outperformed both Disney and Time Warner. But Time Warner's HBO has done better in the awards race both at September's Emmy's and this month's Golden Globes. Ryan explains how traders can utilize E*Trade's drawing tool to better understand the market opportunity for a stock like Netflix.

Share:
More In Business
McDonald's Posts Q4 Earnings Miss; McPlant Burger Takes Off
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Load More